STAT Brand Studio

Our award-winning team creates custom content that inspires, engages, and informs the STAT News audience in medicine, health care, and the life sciences.

[STAT Brand Studio @statbrandstudio]

Cancer care is becoming increasingly personalized.

At STAT@ASCO, @GileadSciences CMO Dietmar Berger discussed how advances in cell therapy, antibody-drug conjugates, and other targeted approaches are helping researchers pursue new ways to treat cancer and improve outcomes for patients.

[STAT Brand Studio @statbrandstudio]

Aliza Apple of @EliLillyandCo and Aleksey Gerasyuto of Schrödinger joined the @statbrandstudio Multimedia Lounge at Breakthrough West to discuss how AI, physics-based modeling, and programmatic R&D are reshaping drug discovery. The conversation explored the cultural and scientific shifts required to move beyond traditional trial-and-error approaches and accelerate the path from discovery to development.

[STAT Brand Studio @statbrandstudio]

Approval is only the beginning.

At STAT@JPM, @CencoraGlobal leaders discussed how specialty distribution, enhanced community provider support, and policy advocacy help ensure complex therapies reach patients.

Read more: https://t.co/sJrsuOqphI

[STAT Brand Studio @statbrandstudio]

Childhood cancer survival is now approaching 85%, up from just 10–20% decades ago.

But progress has come with tradeoffs, including long-term toxicity. A new wave of targeted therapies and technologies could reshape what comes next.

Read more: https://t.co/vtICZJRZk4

[STAT Brand Studio @statbrandstudio]

At @statnews Breakthrough Summit West, @genentech CMO Zoë Lazarre PhD MPH discussed the challenge of translating innovation into real patient impact and how her public health background continues to shape her approach to leadership in biopharma. With experience spanning public health, commercialization, and patient access, Lazarre offered perspective on the evolving relationship between scientific advancement and the people it’s ultimately meant to serve.

[STAT Brand Studio @statbrandstudio]

AI may accelerate drug discovery, but data remains the constraint. At Breakthrough East 2026, @Regeneron Genetics Center’s Gonçalo Abecasis said larger, higher-quality datasets will drive better questions that will drive progress.

Read more: https://t.co/aRsfxqPdp9

[STAT Brand Studio @statbrandstudio]

[Sponsored by Genentech] At a recent @STAT Brand Studio Open Doors event, @Genentech CEO Ashley Magargee outlined three principles behind the company’s long-standing culture of innovation: deep scientific understanding, willingness to take risks, and cross-disciplinary collaboration.

[STAT Brand Studio @statbrandstudio]

Affordable medicines have come a long way, but gaps remain. At Breakthrough East 2026, @Amneal’s Chirag Patel pointed to antibiotic supply chain risks and slow biosimilar adoption as key barriers to access.

Read more: https://t.co/KbclbRBYcl

[STAT Brand Studio @statbrandstudio]

In this podcast episode, oncology leaders Jackson Egen of @GileadSciences and Priti Hegde of Kite, a Gilead company, discuss how unmet patient needs are shaping the next phase of cancer research.

Listen: https://t.co/SB8VQ4UfO9

[STAT Brand Studio @statbrandstudio]

STAT Brand Studio took home two honors at the Native Advertising Institute awards, recognizing excellence in branded content. STAT took home the Gold for Most Effective Campaign and Best Healthcare Program, as well as the Bronze in Branded Content Studio of the Year < 20 employees.

A strong signal of where the industry is heading and the work it takes to get there.

[STAT Brand Studio @statbrandstudio]

Houston has long been a global medical center — now it’s building a scalable platform that’s transforming medicine. In a recent STAT Brand Studio virtual event, leaders discussed how Houston’s infrastructures are accelerating biotech.

Read more: https://t.co/snhaicm94a

[STAT Brand Studio @statbrandstudio]

A new MASH advocacy fellowship is honoring Dr. Stephen Harrison’s legacy—focused on elevating patient voices in liver disease research. Led by the Fatty Liver Foundation with support from @MadrigalPharma.

Read more: https://t.co/Y3UiA5AIQb

[STAT Brand Studio @statbrandstudio]

Advances in targeted therapies are changing the trajectory of blood cancers. Innovators in the field are focusing on building regimens, expanding care beyond academic centers and designing treatments that better fit the lives of people with cancer.

https://t.co/yV5p9a8gTp

[STAT Brand Studio @statbrandstudio]

New proteomics assays are uncovering early biological signals of disease years before symptoms appear.

In a collaboration with @Regeneron's The Nucleus podcast, John Overton discusses how integrating protein data with genomics could shift medicine: https://t.co/crKw7IaCpB

[STAT @statnews]

We’re committed to making STAT events accessible to as many attendees as possible. Our event scholarship program provides financial assistance to cover ticket costs and related expenses, helping more participants join us in person or online.
Apply: https://t.co/0vhfNxx86T

[STAT Brand Studio @statbrandstudio]

China might “win” biotech. U.S. policy could play a role.

MFN pricing and patent fees don’t just impact large pharma. They can slow early-stage innovation and push capital elsewhere.

John Stanford of @incub8coalition explains. Watch more: https://t.co/QdxMMbUYjT

[STAT Brand Studio @statbrandstudio]

What happens after a therapy reaches patients? Dr. Josh Allen of @JazzPharma joins @statnews' Jesse McQuarters to discuss the operational, clinical, and access considerations that shape long-term impact.

[STAT Brand Studio @statbrandstudio]

@statnews Brand Studio editor @JesseMcQuarters is onsite at #STATBreakthrough East in NYC, with sponsored conversations ahead featuring @nyulangone, @Regeneron, @JazzPharma, and @AmnealPharma.